• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小檗碱与健康结局:伞式评价。

Berberine and health outcomes: An umbrella review.

机构信息

Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Department of Chinese Medicine, Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

Phytother Res. 2023 May;37(5):2051-2066. doi: 10.1002/ptr.7806. Epub 2023 Mar 31.

DOI:10.1002/ptr.7806
PMID:36999891
Abstract

Berberine is a plant extract widely used in clinical practice. This review aimed to summarize and to grade the available evidence on the association between berberine consumption and health-related outcomes. The PubMed, Cochrane Library, and Embase databases were searched for meta-analyses of randomized controlled trials (RCTs) assessing the efficacy and safety of berberine from inception to June 30, 2022. The AMSTAR-2 and GRADE system were used to assess the methodological quality and evidence level of the included meta-analyses. A total of 11 eligible meta-analyses were identified from 235 publications, which were published in peer-reviewed journals between 2013 and 2022. The results revealed that berberine significantly affects blood glucose levels, insulin resistance, blood lipids, body parameters and composition, inflammatory markers, colorectal adenomas, and Helicobacter pylori infections as compared to controls. Common side effects of berberine consumption include gastrointestinal symptoms, such as constipation and diarrhea. Berberine is a safe medicinal plant ingredient that improves various clinical outcomes; however, there is a need for improvement of methodological quality in published meta-analyses. Additionally, the clinical effects of berberine need to be confirmed in high-quality RCTs.

摘要

小檗碱是一种广泛应用于临床实践的植物提取物。本综述旨在总结和评估小檗碱摄入与健康相关结局之间关联的现有证据。从建库至 2022 年 6 月 30 日,我们检索了 PubMed、Cochrane Library 和 Embase 数据库中评估小檗碱疗效和安全性的随机对照试验(RCT)的荟萃分析。我们使用 AMSTAR-2 和 GRADE 系统评估纳入荟萃分析的方法学质量和证据水平。从 235 篇出版物中确定了 11 项符合条件的荟萃分析,这些出版物发表于 2013 年至 2022 年的同行评议期刊上。结果表明,与对照组相比,小檗碱显著影响血糖水平、胰岛素抵抗、血脂、身体参数和组成、炎症标志物、结直肠腺瘤和幽门螺杆菌感染。小檗碱的常见副作用包括便秘和腹泻等胃肠道症状。小檗碱是一种安全的药用植物成分,可改善各种临床结局;然而,需要提高已发表荟萃分析的方法学质量。此外,需要在高质量 RCT 中确认小檗碱的临床效果。

相似文献

1
Berberine and health outcomes: An umbrella review.小檗碱与健康结局:伞式评价。
Phytother Res. 2023 May;37(5):2051-2066. doi: 10.1002/ptr.7806. Epub 2023 Mar 31.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: A systematic review and meta-analysis.小檗碱预防结直肠腺瘤复发的疗效和安全性:系统评价和荟萃分析。
J Ethnopharmacol. 2022 Jan 10;282:114617. doi: 10.1016/j.jep.2021.114617. Epub 2021 Sep 10.
4
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.总体及性别特异性评价小檗碱治疗成人血脂异常的效果:一项随机安慰剂对照试验的系统评价和荟萃分析。
Drugs. 2023 Apr;83(5):403-427. doi: 10.1007/s40265-023-01841-4. Epub 2023 Mar 21.
5
Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials.小檗碱治疗血脂异常的疗效和安全性:随机临床试验的系统评价和荟萃分析。
Phytomedicine. 2018 Nov 15;50:25-34. doi: 10.1016/j.phymed.2018.09.212. Epub 2018 Sep 28.
6
Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.单纯使用小檗碱或联合他汀类药物治疗高脂血症的疗效和安全性:一项随机对照临床试验的系统评价和荟萃分析。
Am J Chin Med. 2019;47(4):751-767. doi: 10.1142/S0192415X19500393. Epub 2019 May 16.
7
Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).Cochrane系统评价:渗透性和刺激性泻药用于儿童便秘管理(综述)
Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893.
8
Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study.藏红花(番红花)与健康结果:对荟萃分析的元研究综述及证据图谱研究
Phytomedicine. 2021 Oct;91:153699. doi: 10.1016/j.phymed.2021.153699. Epub 2021 Aug 8.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.粪便微生物群移植与健康结局:随机对照试验荟萃分析的伞状评价。
Front Cell Infect Microbiol. 2022 Jun 27;12:899845. doi: 10.3389/fcimb.2022.899845. eCollection 2022.

引用本文的文献

1
Red yeast rice with monacolin K for the improvement of hyperlipidemia: A narrative review.含莫纳可林K的红曲米改善高脂血症:一项叙述性综述。
World J Clin Cases. 2025 Sep 26;13(27):105415. doi: 10.12998/wjcc.v13.i27.105415.
2
The effects of Gegen Qinlian decoction and its main constituents on glucolipid metabolic disorders in diabetes: an overview of systematic reviews and meta-analysis.葛根芩连汤及其主要成分对糖尿病糖脂代谢紊乱的影响:系统评价与Meta分析综述
Syst Rev. 2025 Jul 30;14(1):158. doi: 10.1186/s13643-025-02914-z.
3
Targeting Skin Neoplasms: A Review of Berberine's Anticancer Properties.
靶向皮肤肿瘤:小檗碱抗癌特性综述
Cells. 2025 Jul 8;14(14):1041. doi: 10.3390/cells14141041.
4
New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products.天然产物治疗代谢功能障碍相关脂肪性肝病的新方法。
ILIVER. 2024 Nov 8;3(4):100131. doi: 10.1016/j.iliver.2024.100131. eCollection 2024 Dec.
5
In vitro assessment of berberine-loaded carboxymethyl chitosan hydrogel: A promising antimicrobial candidate for S. aureus-induced bovine mastitis treatment.载黄连素羧甲基壳聚糖水凝胶的体外评估:一种用于治疗金黄色葡萄球菌引起的牛乳腺炎的有前景的抗菌候选物。
PLoS One. 2025 Jun 27;20(6):e0326574. doi: 10.1371/journal.pone.0326574. eCollection 2025.
6
Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses.姜黄素与多种健康结局:干预性荟萃分析的批判性伞状评价
Front Pharmacol. 2025 Jun 5;16:1601204. doi: 10.3389/fphar.2025.1601204. eCollection 2025.
7
Development of Traditional Chinese Medicine in combination with EGFR Inhibitors against Cancer.中药与表皮生长因子受体抑制剂联合用于抗癌的研究进展
J Cancer. 2025 Jun 5;16(8):2595-2612. doi: 10.7150/jca.109420. eCollection 2025.
8
Berberine as a multi-target therapeutic agent for obesity: from pharmacological mechanisms to clinical evidence.黄连素作为肥胖症的多靶点治疗药物:从药理机制到临床证据
Eur J Med Res. 2025 Jun 12;30(1):477. doi: 10.1186/s40001-025-02738-6.
9
Targeting autophagy in astrocytes: a potential for neurodegenerative disease intervention.靶向星形胶质细胞中的自噬:神经退行性疾病干预的一种潜力。
Front Cell Neurosci. 2025 Apr 28;19:1584767. doi: 10.3389/fncel.2025.1584767. eCollection 2025.
10
Berberine-Functionalized Bismuth-Doped Carbon Dots in a Pathogen-Responsive Hydrogel System: A Multifaceted Approach to Combating Periodontal Diseases.病原体响应水凝胶系统中黄连素功能化铋掺杂碳点:一种对抗牙周疾病的多方面方法
ACS Nano. 2025 May 13;19(18):17554-17577. doi: 10.1021/acsnano.5c00561. Epub 2025 May 2.